DAFNA Capital Management’s Wave Life Sciences WVE Stock Holding History

DAFNA Capital Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-372,361	Closed	-$1.21M	–	93
2022 Q2	$1.21M	Sell	372,361 -17,800	-5%	-$34.2K	0.33%	59
2022 Q1	$780K	Hold	390,161	–	–	0.2%	74
2021 Q4	$1.23M	Buy	+390,161	New	+$1.62M	0.31%	61
2020 Q1	–	Sell	-36,960	Closed	-$296K	–	86
2019 Q4	$296K	Sell	36,960 -160,594	-81%	-$3.94M	0.1%	77
2019 Q3	$4.06M	Sell	197,554 -20,000	-9%	-$459K	1.53%	19
2019 Q2	$5.68M	Buy	217,554 +27,000	+14%	+$757K	2.13%	11
2019 Q1	$7.4M	Buy	190,554 +142,654	+298%	+$5.79M	3.19%	6
2018 Q4	$2.01M	Hold	47,900	–	–	1%	30
2018 Q3	$2.4M	Hold	47,900	–	–	0.98%	35
2018 Q2	$1.83M	Buy	47,900 +3,500	+8%	+$151K	0.86%	33
2018 Q1	$1.78M	Buy	+44,400	New	+$1.87M	0.87%	33

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

DAFNA Capital Management's WVE Position: Q3 2022 in Review

DAFNA Capital Management sold out of Wave Life Sciences (WVE) in Q3 2022, closing a stake of 372,361 shares — an estimated $1.21M sold.

DAFNA Capital Management first reported a position in WVE in Q1 2018 and held it in 11 quarters. The position peaked at $7.4M in Q1 2019. 61 funds tracked by Wall St. Rank hold WVE as of Q3 2022.

DAFNA Capital Management reported no remaining Wave Life Sciences position as of Q3 2022 after selling out during the quarter.
DAFNA Capital Management sold 372,361 Wave Life Sciences shares in Q3 2022, an estimated $1.21M.
DAFNA Capital Management first reported a position in Wave Life Sciences in Q1 2018 and held it in 11 quarters.
DAFNA Capital Management's Wave Life Sciences position peaked at $7.4M in Q1 2019.
61 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2022.

Based on DAFNA Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.